Smoking causes polycythemia primarily by flooding the bloodstream with carbon monoxide, which hijacks hemoglobin and starves tissues of oxygen. The body reads that oxygen shortage as a signal to produce more red blood cells, pushing the hematocrit (the fraction of blood made up of red cells) above normal levels. But carbon monoxide is not the only mechanism at work, and the resulting thickened blood carries real cardiovascular risk that persists as long as a person keeps smoking.
Carbon Monoxide and the Oxygen Squeeze
Every puff of tobacco smoke delivers carbon monoxide into the lungs. Carbon monoxide binds to hemoglobin roughly 200 times more readily than oxygen does, forming carboxyhemoglobin. In chronic smokers, carboxyhemoglobin levels can climb as high as 10 percent of total hemoglobin, compared with less than 1 percent in nonsmokers.1Military Medicine. Acute and Chronic Carbon Monoxide Toxicity from Tobacco Smoking That means up to a tenth of the blood’s oxygen-carrying molecules are effectively taken offline.
The problem compounds from there. Carbon monoxide does not just block hemoglobin from picking up oxygen; it also changes the shape of the hemoglobin molecule in a way that makes the remaining oxygen-carrying sites grip oxygen more tightly. This “left shift” of the oxygen-hemoglobin dissociation curve means hemoglobin is less willing to release oxygen to tissues that need it. In one landmark study of 22 heavy smokers with elevated hematocrits (averaging 54 percent), the mean carboxyhemoglobin was 11.6 percent, and the P50 (the oxygen pressure at which hemoglobin is half-saturated) dropped to 21.6 torr, well below the normal 26.7.2PubMed. Smokers’ polycythemia In plain terms, their blood was both carrying less oxygen and holding on to what it had more stubbornly.
How the Body Overcompensates
When tissues sense they are not getting enough oxygen, the kidneys ramp up production of erythropoietin, the hormone that tells the bone marrow to churn out more red blood cells. This is the same response that kicks in at high altitude or in people with chronic lung disease. In a healthy person, the system self-corrects once oxygen delivery improves. In a daily smoker, however, carbon monoxide is replenished with every cigarette, so the stimulus never goes away. The marrow keeps producing red cells, and the hematocrit creeps upward over months and years.
This erythropoietin-driven increase in red-cell mass is considered a “secondary” polycythemia because it is a reaction to an external cause rather than a problem originating inside the bone marrow itself. In the same study of heavy smokers mentioned above, red-cell volume was increased in 14 of the 18 patients whose blood volume was measured directly.2PubMed. Smokers’ polycythemia The bone marrow was doing exactly what it was designed to do; it was just responding to a signal that would not stop.
Plasma Volume Contraction and “Apparent” Polycythemia
Not every smoker with an elevated hematocrit has extra red cells. In some cases, the liquid portion of the blood (plasma) shrinks, making the red cells appear more concentrated even though the actual red-cell mass is normal. This condition, sometimes called Gaisbock syndrome or “stress polycythemia,” has been linked to smoking, high blood pressure, obesity, and chronic stress.
Smoking can contribute to plasma volume contraction in several ways. Nicotine stimulates the sympathetic nervous system, which tightens blood vessels and can reduce the volume of circulating plasma. Chronic dehydration, common in heavy smokers who may replace water intake with coffee and cigarettes, plays a role too. In that same landmark study, plasma volume was reduced in 14 of the 18 smokers studied, and many patients had both an increased red-cell mass and a contracted plasma volume happening simultaneously.2PubMed. Smokers’ polycythemia Early clinical descriptions of these patients noted a characteristic profile: overweight, stocky build, a flushed face, and an anxious temperament, alongside smoking habits and vascular disease.3PubMed. Gaisbock Syndrome: A Review of Contemporary Studies, Pathogenesis, Complications, and Possible Treatment
This distinction matters clinically. A person with true polycythemia (more red cells than normal) faces a different set of risks than someone with apparent polycythemia (normal red cells concentrated in less plasma). Both show up as a high hematocrit on a routine blood test, but the treatment and prognosis differ. Sorting out which is which often requires direct measurement of red-cell mass and plasma volume, or at least careful clinical evaluation.
When Lung Damage Adds a Second Layer
Years of smoking commonly leads to chronic obstructive pulmonary disease (COPD), and COPD introduces its own path to polycythemia. Damaged lungs transfer oxygen poorly, so blood oxygen levels fall even between cigarettes. The kidneys respond to that chronic low oxygen by pushing erythropoietin production even harder. In effect, a long-term smoker who develops COPD can have two overlapping drivers: carbon monoxide stealing hemoglobin capacity, and diseased lungs failing to load oxygen onto what hemoglobin remains.
A large study of COPD patients found that current smoking roughly doubled the odds of polycythemia even after adjusting for the severity of lung disease itself. Other risk factors included severe resting low oxygen levels and impaired gas transfer across the lung membrane.4PubMed Central. Secondary polycythemia in chronic obstructive pulmonary disease: prevalence and risk factors That finding is telling: even among people who already have damaged lungs, the act of continuing to smoke adds a measurable independent risk on top of the lung damage.
The Blood Viscosity Problem
Having extra red blood cells is not just an abnormal lab value. It changes the physical properties of the blood. The more packed with red cells blood becomes, the thicker and more viscous it gets. Thicker blood moves more slowly through small vessels, is harder for the heart to pump, and is more prone to clotting. This is where smoking-induced polycythemia translates into real clinical danger.
Increased blood viscosity in smokers has been correlated with changes in cerebral blood flow and cardiac output, and it raises the risk of blood clots forming where they should not.5PubMed. Alterations in Blood Coagulation and Viscosity Among Young Male Cigarette Smokers of Al-Jouf Region in Saudi Arabia This partly explains why smokers have elevated rates of stroke and heart attack beyond what can be attributed to arterial plaque alone. The blood itself becomes a risk factor, sluggish and quick to clot. Symptoms that smokers sometimes dismiss as minor annoyances, like persistent headaches, dizziness, or tingling in the hands and feet, can be signs of polycythemia-related hyperviscosity.
Telling Smokers’ Polycythemia from Polycythemia Vera
When a smoker shows up with a high hematocrit, one of the first clinical tasks is figuring out whether smoking is the whole explanation or whether something more serious is going on. Polycythemia vera (PV) is a blood cancer in which a mutation in the bone marrow, almost always in the JAK2 gene, causes uncontrolled red cell production. More than 95 percent of PV patients carry a JAK2 variant, which provides a clear dividing line from secondary causes like smoking or sleep apnea.6JAMA. Diagnosis and Treatment of Polycythemia Vera: A Review
In practice, doctors typically check erythropoietin levels and test for the JAK2 mutation. In smoking-related polycythemia, erythropoietin is usually normal or slightly elevated because the body is appropriately responding to low oxygen. In PV, erythropoietin is often low because the marrow is producing red cells on its own without needing the hormone’s signal. The JAK2 test settles most ambiguous cases.
There is, however, an unsettling hypothesis in the research literature. Some investigators have proposed that the chronic inflammatory environment created by years of heavy smoking, particularly the persistent stimulation of the JAK signaling pathway and the inflammatory molecule NF-κB, might in rare cases actually help trigger or accelerate the clonal expansion that leads to myeloproliferative neoplasms like PV.7Leukemia Research. Smoking as a contributing factor for development of polycythemia vera and related neoplasms This remains speculative and is not established fact, but it is a reminder that smoking’s effects on blood production reach deeper than just the oxygen-hemoglobin math.
Does the Type of Tobacco Matter?
Cigarettes are the most studied culprit, but they are not the only form of tobacco that pushes red cell counts up. A cross-sectional study comparing cigarette smokers, shisha (hookah) smokers, and people who used both found that hemoglobin levels climbed in a stepwise fashion: nonsmokers averaged about 169 g/L, cigarette-only smokers about 171 g/L, shisha-only smokers about the same, and dual users about 175 g/L. Among the smokers, over half had hemoglobin in the polycythemic range.8Saudi Journal of Biological Sciences. Association between cigarette & shisha smoking and the severity of polycythemia: A cross sectional study Shisha sessions tend to last longer than a single cigarette and can generate substantial carbon monoxide exposure, which likely explains the similar or slightly higher hemoglobin levels in that group.
E-cigarettes and vaping products present a murkier picture. Because vaping heats a liquid rather than burning tobacco, it produces little to no carbon monoxide, which should theoretically eliminate the main driver of smokers’ polycythemia. One small study comparing young male vapers and cigarette smokers found that vapers actually had the highest red blood cell counts of any group, though other blood parameters did not differ significantly.9Iraqi Journal of Hematology. Comparative effects of vaping and cigarette smoking on hematological parameters in young male university students That result is hard to interpret from a single study with a small sample size, and researchers have not yet worked out whether nicotine itself, flavorings, or other aerosol components could independently stimulate red cell production. The honest answer is that we do not know yet whether vaping carries a polycythemia risk comparable to cigarettes.
Heat-not-burn tobacco products, which warm tobacco without combustion, fall somewhere in between. Because they still contain tobacco, they deliver nicotine and some toxicants, but they produce far less carbon monoxide than conventional cigarettes. In a study of polycythemic smokers, switching from cigarettes to a heat-not-burn product improved hematocrit to levels comparable with quitting entirely. Patients in the heat-not-burn group also saw relief from symptoms like headache, numbness, and dizziness.10PubMed Central. Introducing heat-not-burn tobacco improves hematocrit and cigarette smoking-related symptoms in patients with smokers’ polycythemia and polycythemia vera That does not make heat-not-burn products safe, but it supports the idea that carbon monoxide, more than nicotine, is the primary driver of smoking-related polycythemia.
What Happens After You Quit
The good news is that smokers’ polycythemia is reversible. Carbon monoxide clears from the blood within hours of the last cigarette, and once carboxyhemoglobin levels drop, the oxygen-sensing system stops screaming for more red blood cells. In polycythemic smokers who quit, hemoglobin and hematocrit fell significantly within just three months.11PubMed Central. Effect of smoking and smoking cessation on hematological parameters in polycythemic patients
Full normalization of all blood cell counts takes longer. A population-based study found that most red-cell parameters returned to nonsmoker levels within two years of quitting, but some white blood cell types, particularly lymphocytes and monocytes, took between two and five years to fully normalize.12PubMed. Quitting smoking may restore hematological characteristics within five years The red-cell side of the equation corrects relatively quickly because the stimulus (carbon monoxide) disappears almost immediately. The lingering white-cell abnormalities likely reflect the slower resolution of chronic inflammation and immune activation caused by years of smoke exposure.
For smokers who cannot or will not quit, doctors sometimes manage severe polycythemia with therapeutic phlebotomy, which is essentially a controlled blood draw to bring the hematocrit down. This treats the symptom but does nothing about the underlying cause, and the hematocrit climbs right back if the person keeps smoking. Quitting remains the only intervention that addresses the root problem.
A Counterintuitive Effect in the Bone Marrow
One wrinkle that complicates the neat story of “smoking drives red-cell production” comes from the bone marrow itself. Cotinine, the main breakdown product of nicotine, appears to suppress the growth of blood cell progenitors, including the precursors that become red blood cells. At concentrations matching what is actually found in smokers’ blood, cotinine inhibited colony formation of red-cell precursors in a dose-dependent fashion.13STEM CELLS. Cotinine (a Metabolite of Nicotine) Suppresses the Growth of Hematopoietic Prognitor Cells at the Concentration Range Equivalent to Its Serum Levels in Smokers Nicotine itself showed no suppression at typical blood levels.
This means smoking simultaneously pushes the body to demand more red blood cells (through hypoxia and carbon monoxide) while one of its own chemical byproducts tries to slow down the marrow’s ability to produce them. The net result in most heavy smokers is still polycythemia, meaning the oxygen-deprivation signal overpowers the cotinine brake. But this tug-of-war may partly explain why not every smoker develops a dramatically elevated hematocrit, even at similar smoking intensities. It also raises the question of whether nicotine-replacement therapies (which deliver nicotine and produce cotinine but no carbon monoxide) might have subtle suppressive effects on blood cell production, though that has not been studied in detail.
When to Take an Elevated Hematocrit Seriously
Many smokers learn about their elevated hematocrit incidentally, when a routine blood draw comes back with a flag. The temptation is to shrug it off since the person otherwise feels fine. But a persistently high hematocrit in a smoker is not a benign finding. Beyond the viscosity-related risks of clotting, stroke, and heart attack already discussed, it may signal that lung function is declining faster than the person realizes. In the COPD study noted earlier, the relationship between smoking, impaired lung gas exchange, and polycythemia was clear and graded: the worse the lung function, the higher the odds.4PubMed Central. Secondary polycythemia in chronic obstructive pulmonary disease: prevalence and risk factors
A high hematocrit also demands that the possibility of polycythemia vera be ruled out. While smoking-related polycythemia is far more common than PV, the two can coexist, and PV requires specific treatment including sometimes blood-thinning medication and drugs that target the JAK2 pathway.6JAMA. Diagnosis and Treatment of Polycythemia Vera: A Review A smoker who assumes a high hematocrit is “just from the cigarettes” and skips further testing could miss a treatable blood cancer. If you smoke and your blood counts come back high, it is worth having the conversation with a doctor about whether additional testing is warranted.